-transparent.png){kind=logo}
We report a case of sustained disease-free survival following second autologous marrow transplantation (BMT) in a patient with Hodgkin's lymphoma which had recurred following several conventional chemotherapy regimens as well as a prior autologous transplant. The initial autologous BMT was performed in fourth complete remission and followed high-dose cyclophosphamide, etoposide and thiotepa. The disease recurred 8 months later and the patient underwent a second ABMT following conditioning with busulfan and cyclophosphamide 1 year after his first transplant. Aside from slow engraftment, his course was uncomplicated. This patient remains in complete remission more than 4 years and 6 months following the second transplantation. This case demonstrates that second autologous transplantation can result in sustained disease-free survival in individuals with Hodgkin's disease with recurrence following initial transplantation.
B R Avalos, and
E A Copelan
January 1990,
Nouvelle revue francaise d'hematologie,
B R Avalos, and
E A Copelan
November 1985,
Revue francaise de transfusion et immuno-hematologie,
B R Avalos, and
E A Copelan
February 1987,
Deutsche medizinische Wochenschrift (1946),
B R Avalos, and
E A Copelan
February 1995,
Journal of hematotherapy,
B R Avalos, and
E A Copelan
September 1992,
Annals of oncology : official journal of the European Society for Medical Oncology,
B R Avalos, and
E A Copelan
September 1997,
Leukemia & lymphoma,
B R Avalos, and
E A Copelan
January 1992,
Leukemia & lymphoma,
B R Avalos, and
E A Copelan
June 1990,
Neurology,
B R Avalos, and
E A Copelan
August 1994,
Seminars in oncology,
B R Avalos, and
E A Copelan
February 1986,
Clinics in haematology,
